Nippon India Pharma Fund
Sectoral/ Thematic · Nippon Life India Asset Management Limited
Among the 946 funds in its category, this one has grown money faster than most. ₹1 lakh invested 5 years ago would be about ₹1.8 lakh today. Investing ₹10,000 every month for the last 10 years would have put in ₹12.1 lakh and grown it to about ₹32 lakh. Be warned: in its worst stretch, ₹1 lakh briefly shrank to about ₹75,980. Expect meaningful ups and downs on the way.
New to fund research? Start with the 5-minute guide. The detailed numbers below back all of this up.Nippon India Pharma Fund is a Sectoral/ Thematic fund from Nippon Life India Asset Management Limited. It has a track record of about 13.7 years. As of the latest data it carries an RS rating of 75/99 (its recent momentum versus category peers) and a King Score of 69/100 (a long-term quality composite). The current NAV is ₹630.52 (as of 2026-09-16).
Growth of ₹100 - last 5 years
Nippon India Pharma Fund returns: last 1, 3, 5 and 10 years
| Period | This fund | Category average |
|---|---|---|
| 1 month | -2.17% | -3.47% |
| 3 months | 4.7% | 2.0% |
| 6 months | 11.89% | 10.56% |
| 1 year | 8.94% | 4.78% |
| 3 years (CAGR) | 17.54% | 13.85% |
| 5 years (CAGR) | 13.07% | 12.48% |
| 10 years (CAGR) | 15.45% | 14.18% |
The last 10 years return of Nippon India Pharma Fund works out to 15.45% a year (CAGR) - ₹1 lakh invested 10 years ago would be about ₹4.2 lakh today. The last 5 years return is 13.07% a year (₹1 lakh → ₹1.8 lakh), and the last 3 years return is 17.54% - ahead of its category's 13.85% average by 3.7 points. Its trailing one-year return is 8.94%. Trailing returns flatter or disappoint depending on the end date you pick - the year-by-year and rolling-return sections below are a fairer read.
Year-by-year returns
| Year | Nippon India Pharma Fu | Benchmark |
|---|---|---|
| 2018 | +4.6% | -7.8% |
| 2019 | +2.5% | -9.3% |
| 2020 | +67.9% | +60.6% |
| 2021 | +25.1% | +10.1% |
| 2022 | -9.1% | -11.4% |
| 2023 | +40.4% | +33.6% |
| 2024 | +35.3% | +39.1% |
| 2025 | -2.5% | -2.9% |
| 2026 | +10.7% | +15.2% |
Nippon India Pharma Fund beat its benchmark in 7 of the last 9 calendar years. That is a strong hit-rate - most active funds fail to clear their index this often. Consistency against the benchmark matters more than any single great year.
Calendar-year returns show how bumpy the ride really was - an average hides the good years and the ugly ones.
What a monthly SIP in Nippon India Pharma Fund would have made
A ₹10,000-a-month SIP, using this fund's actual NAV history. SIP returns (XIRR) differ from lumpsum CAGR because your money goes in gradually, averaging your entry price.
| SIP duration | You invested | It became | XIRR |
|---|---|---|---|
| 3 years | ₹370,000 | ₹447,003 | 12.66% |
| 5 years | ₹610,000 | ₹930,110 | 16.87% |
| 10 years | ₹1,210,000 | ₹3,201,063 | 18.47% |
Over 10 years, ₹1,210,000 invested in monthly instalments would have grown to about ₹3,201,063 - an XIRR of 18.47%. Figures are pre-tax and assume you stayed invested throughout.
Risk & drawdowns
| Measure | This fund | Category average |
|---|---|---|
| Worst drawdown (lifetime) | -24.02% | -26.37% |
| Worst drawdown (3Y) | -14.72% | -20.9% |
| Volatility (1Y) | 14.02% | 19.02% |
| Sharpe (3Y) | 0.82 | 0.31 |
| Sortino (3Y) | 1.36 | 0.82 |
| Beta (3Y) | 0.89 | 0.91 |
| Alpha (3Y) | 0.1% | 6.12% |
| Up capture | 89.6% | 97.13% |
| Down capture | 87.5% | 81.47% |
| Bull-market return | 25.9% | 30.78% |
| Bear-market return | -4.4% | -23.76% |
Timing matters more than people admit: the best possible 1-year stretch in Nippon India Pharma Fund (starting 2020-03-23) gained 90.7%, while the worst (starting 2016-09-08) lost 15.1%. The worst peak-to-bottom fall Nippon India Pharma Fund has ever put investors through is -24.02% - the real test of whether you'd have stayed invested. In falling markets (Nifty below its 200-day average) it has returned about -4.4% annualised, versus 25.9% in rising markets. It has captured roughly 89.6% of its benchmark's up-moves and 87.5% of its down-moves.
How Nippon India Pharma Fund behaves when markets fall
When the market is falling (the Nifty below its 200-day average), Nippon India Pharma Fund has historically returned about -4.4% annualised, versus roughly 25.9% when the market is rising. Its deepest fall on record is -24.02%. Right now it sits about 2.6% below its all-time high (last hit 2026-08-12). The real question isn't the average year - it's whether you could hold on through the worst one.
How Nippon India Pharma Fund ranks in its category
Percentile versus its ~946 category peers - 100th is best-in-class, 50th is average. This is the fairest apples-to-apples read.
Consistency (rolling returns)
| Measure | Value |
|---|---|
| Median 3Y rolling CAGR | 19.93% |
| 3Y windows positive | 98.5% |
| Worst 3Y window | -1.33% |
| 3Y windows beating Nifty 500 | 74.0% |
| Median 5Y rolling CAGR | 16.83% |
| Median 10Y rolling CAGR | 16.17% |
Instead of one lucky start date, rolling returns test every start date. Across all 3-year windows in its history, Nippon India Pharma Fund returned a median of 19.93% a year, and 98.5% of those windows were positive.
What Nippon India Pharma Fund holds
Its latest monthly portfolio disclosure. This is what your money actually owns.
Top holdings
Sector allocation
The top 10 holdings make up 58.8% of the portfolio, across 34 stocks. A higher concentration means the fund's fortunes ride on fewer names.
Portfolio overlap with similar funds
Nippon India Pharma Fund shares HDFC Transportation and Logistics Fund (0%), ICICI Prudential Transportation And Logistics Fund (0%), ICICI Prudential Innovation Fund (0%) of its portfolio with these category peers (overlap = the slice of the two portfolios invested in the same stocks). The lower the overlap, the more genuinely different the portfolios are.
Who manages Nippon India Pharma Fund - and how good are they?
Nippon India Pharma Fund is managed by Sailesh Raj Bhan, Kinjal Desai and Amber Singhania. Below is each manager's complete track record - every fund they currently run, judged on the same numbers as everything else on this page - so you can see whether this fund is in strong hands or is the outlier in a weak book.
Sailesh Raj Bhan's full record
Sailesh Raj Bhan currently runs 6 funds, across Large Cap Fund, Multi Cap Fund, Sectoral/ Thematic, with about ₹227,414 Cr under management. The book's average King Score is 67.7/100. Their strongest fund by King Score is Nippon India Large Cap Fund (78/100); Nippon India Pharma Fund ranks #3 of 6 in their book.
Tap any column heading to sort.
| # | Fund | RS | King | 3M | 6M | 1Y | 3Y CAGR | 5Y CAGR | 10Y CAGR | Sharpe | Roll 3Y | Worst fall |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Nippon India Large Cap Fund | 34 | 78 | -1.7% | 0.1% | -5.2% | 9.9% | 12.6% | 13.9% | 0.24 | 16.8% | -40.0% |
| 2 | Nippon India Large Cap Fund | 34 | 78 | -1.7% | 0.1% | -5.2% | 9.9% | 12.6% | 13.9% | 0.24 | 16.8% | -40.0% |
| 3 | Nippon India Pharma Fund (this page) | 75 | 69 | 4.7% | 11.9% | 8.9% | 17.5% | 13.1% | 15.4% | 0.82 | 19.9% | -24.0% |
| 4 | Nippon India Pharma Fund | 75 | 69 | 4.7% | 11.9% | 8.9% | 17.5% | 13.1% | 15.4% | 0.82 | 19.9% | -24.0% |
| 5 | Nippon India Multi Cap Fund | 15 | 56 | -1.2% | 3.9% | -2.8% | 12.1% | 16.1% | 15.3% | 0.37 | 17.3% | -42.8% |
| 6 | Nippon India Multi Cap Fund | 15 | 56 | -1.2% | 3.9% | -2.8% | 12.1% | 16.1% | 15.3% | 0.37 | 17.3% | -42.8% |
Kinjal Desai's full record
Kinjal Desai currently runs 51 funds, across Aggressive Hybrid Fund, Arbitrage Fund, Conservative Hybrid Fund, Corporate Bond Fund and more, with about ₹687,720 Cr under management. The book's average King Score is 71.3/100. Their strongest fund by King Score is Nippon India Corporate Bond Fund (91/100); Nippon India Pharma Fund ranks #31 of 51 in their book.
Tap any column heading to sort.
| # | Fund | RS | King | 3M | 6M | 1Y | 3Y CAGR | 5Y CAGR | 10Y CAGR | Sharpe | Roll 3Y | Worst fall |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Nippon India Corporate Bond Fund | 88 | 91 | 1.3% | 3.0% | 5.5% | 7.5% | 6.8% | 7.3% | 0.86 | 8.0% | -1.7% |
| 2 | Nippon India Nivesh Lakshya Long Duration Fund | 87 | 90 | 1.1% | 1.8% | 2.2% | 6.1% | 5.6% | n/a | -0.11 | 6.9% | -5.8% |
| 3 | Nippon India Liquid Fund | 97 | 86 | 1.7% | 3.5% | 6.6% | 7.0% | 6.4% | 6.2% | 1.34 | 6.9% | -0.2% |
| 4 | Nippon India Low Duration Fund | 96 | 86 | 1.7% | 3.4% | 6.6% | 7.5% | 6.7% | 7.0% | 1.58 | 7.5% | -2.0% |
| 5 | Nippon India Money Market Fund | 91 | 86 | 1.9% | 3.5% | 6.6% | 7.4% | 6.8% | 6.8% | 1.59 | 7.4% | -0.9% |
| 6 | Nippon India Money Market Fund | 91 | 86 | 1.9% | 3.5% | 6.6% | 7.4% | 6.8% | 6.8% | 1.59 | 7.4% | -0.9% |
| 7 | Nippon India Short Duration Fund | 86 | 83 | 1.2% | 2.8% | 5.8% | 7.7% | 6.7% | 7.3% | 1.11 | 7.9% | -2.9% |
| 8 | Nippon India Conservative Hybrid Fund | 99 | 82 | 1.6% | 3.5% | 7.0% | 8.5% | 8.2% | 6.0% | 0.97 | 8.5% | -18.9% |
| 9 | Nippon India Multi Asset Allocation Fund | 87 | 81 | 0.9% | 4.8% | 11.7% | 18.3% | 15.2% | n/a | 1.16 | 18.4% | -9.5% |
| 10 | Nippon India Ultra Short Duration Fund | 97 | 80 | 1.9% | 3.7% | 7.1% | 7.6% | 7.0% | n/a | 2.0 | 7.0% | -5.2% |
| 11 | Nippon India Gilt Fund | 84 | 80 | 1.2% | 2.7% | 3.9% | 6.3% | 5.6% | 7.4% | -0.07 | 9.3% | -6.5% |
| 12 | Nippon India Low Duration Fund | 96 | 78 | 1.7% | 3.4% | 6.6% | 7.5% | 6.7% | 7.0% | 1.58 | 7.2% | -10.5% |
| 13 | Nippon India Large Cap Fund | 34 | 78 | -1.7% | 0.1% | -5.2% | 9.9% | 12.6% | 13.9% | 0.24 | 16.8% | -40.0% |
| 14 | Nippon India Large Cap Fund | 34 | 78 | -1.7% | 0.1% | -5.2% | 9.9% | 12.6% | 13.9% | 0.24 | 16.8% | -40.0% |
| 15 | Nippon India Mid Cap Fund | 38 | 77 | -0.5% | 7.8% | 5.7% | 17.3% | 17.2% | 18.1% | 0.62 | 22.0% | -35.3% |
| 16 | Nippon India Mid Cap Fund | 38 | 77 | -0.5% | 7.8% | 5.7% | 17.3% | 17.2% | 18.1% | 0.62 | 22.0% | -35.3% |
| 17 | Nippon India Arbitrage Fund | 86 | 76 | 1.6% | 3.1% | 6.7% | 7.3% | 6.8% | 6.5% | 0.83 | 6.9% | -0.6% |
| 18 | Nippon India Dynamic Bond Fund | 69 | 76 | 0.8% | 1.8% | 5.2% | 7.2% | 6.2% | 6.7% | 0.36 | 7.6% | -8.5% |
| 19 | Nippon India Vision Large & Mid Cap Fund | 20 | 76 | -0.9% | 3.8% | -1.5% | 13.4% | 12.3% | 12.7% | 0.44 | 16.9% | -45.0% |
| 20 | Nippon India Vision Large & Mid Cap Fund | 20 | 76 | -0.9% | 3.8% | -1.5% | 13.4% | 12.3% | 12.7% | 0.44 | 16.9% | -45.0% |
| 21 | Nippon India Credit Risk Fund | 75 | 75 | 1.8% | 3.9% | 8.0% | 8.9% | 7.9% | 6.6% | 2.65 | 8.7% | -13.8% |
| 22 | Nippon India Taiwan Equity Fund | 99 | 74 | -6.9% | 38.3% | 112.8% | 58.2% | n/a | n/a | 1.33 | 36.4% | -44.8% |
| 23 | Nippon India Medium Duration Fund | 98 | 74 | 2.9% | 3.3% | 6.6% | 8.6% | 6.9% | 3.8% | 1.09 | 7.0% | -29.8% |
| 24 | Nippon India Gilt Fund | 84 | 74 | 1.2% | 2.7% | 3.9% | 6.3% | 5.6% | 7.4% | -0.07 | 9.2% | -11.8% |
| 25 | Nippon India Value Fund | 28 | 72 | -2.4% | 1.4% | -3.6% | 12.9% | 13.0% | 14.8% | 0.4 | 19.1% | -38.6% |
| 26 | Nippon India US Equity Opportunities Fund | 87 | 71 | 6.8% | 17.5% | 16.5% | 19.5% | 12.2% | 16.3% | 0.76 | 16.7% | -30.8% |
| 27 | Nippon India Medium Duration Fund | 72 | 71 | 1.4% | 2.9% | 6.2% | 8.3% | 6.8% | 3.7% | 0.97 | 7.0% | -29.8% |
| 28 | Nippon India Innovation Fund | 68 | 71 | 4.6% | 12.8% | 0.8% | 13.9% | n/a | n/a | 0.49 | n/a | -21.5% |
| 29 | Nippon India Japan Equity Fund | 89 | 70 | 4.1% | 15.1% | 28.8% | 20.8% | 10.1% | 11.9% | 0.75 | 8.1% | -29.9% |
| 30 | Nippon India Japan Equity Fund | 89 | 70 | 4.1% | 15.1% | 28.8% | 20.8% | 10.1% | 11.9% | 0.75 | 8.1% | -29.9% |
| 31 | Nippon India Pharma Fund (this page) | 75 | 69 | 4.7% | 11.9% | 8.9% | 17.5% | 13.1% | 15.4% | 0.82 | 19.9% | -24.0% |
| 32 | Nippon India Pharma Fund | 75 | 69 | 4.7% | 11.9% | 8.9% | 17.5% | 13.1% | 15.4% | 0.82 | 19.9% | -24.0% |
| 33 | Nippon India ELSS Tax Saver Fund | 31 | 68 | -1.6% | 2.2% | -0.8% | 11.1% | 11.2% | 10.5% | 0.3 | 15.5% | -51.9% |
| 34 | Nippon India Power & Infra Fund | 45 | 67 | -3.3% | 7.6% | 6.0% | 17.2% | 19.8% | 17.4% | 0.57 | 17.9% | -53.2% |
| 35 | Nippon India Power & Infra Fund | 45 | 67 | -3.3% | 7.6% | 6.0% | 17.2% | 19.8% | 17.4% | 0.57 | 17.9% | -53.2% |
| 36 | Nippon India Aggressive Hybrid Fund | 57 | 66 | -0.1% | 2.8% | -0.2% | 9.8% | 10.6% | 9.8% | 0.3 | 13.9% | -42.4% |
| 37 | Nippon India Gilt Fund | 84 | 64 | 1.2% | 2.7% | 3.9% | 6.3% | 5.6% | 7.4% | -0.07 | 6.9% | -36.5% |
| 38 | Nippon India Quant Fund | 23 | 64 | -1.0% | 0.4% | -1.3% | 12.7% | 12.5% | 13.7% | 0.38 | 13.5% | -32.8% |
| 39 | Nippon India Quant Fund | 23 | 64 | -1.0% | 0.4% | -1.3% | 12.7% | 12.5% | 13.7% | 0.38 | 13.6% | -32.8% |
| 40 | Nippon India Small Cap Fund | 40 | 62 | 3.3% | 17.1% | 7.2% | 14.3% | 18.2% | 20.9% | 0.46 | 25.8% | -48.6% |
| 41 | Nippon India Small Cap Fund | 40 | 62 | 3.3% | 17.1% | 7.2% | 14.3% | 18.2% | 20.9% | 0.46 | 25.8% | -48.6% |
| 42 | Nippon India Flexi Cap Fund | 40 | 56 | -0.1% | 5.6% | -2.1% | 9.4% | 10.4% | n/a | 0.19 | 17.2% | -19.8% |
| 43 | Nippon India Multi Cap Fund | 15 | 56 | -1.2% | 3.9% | -2.8% | 12.1% | 16.1% | 15.3% | 0.37 | 17.3% | -42.8% |
| 44 | Nippon India Multi Cap Fund | 15 | 56 | -1.2% | 3.9% | -2.8% | 12.1% | 16.1% | 15.3% | 0.37 | 17.3% | -42.8% |
| 45 | Nippon India Banking & Financial Services Fund | 40 | 55 | -0.5% | 2.5% | 2.7% | 10.9% | 12.7% | 12.9% | 0.28 | 16.5% | -50.6% |
| 46 | Nippon India Banking & Financial Services Fund | 40 | 55 | -0.5% | 2.5% | 2.7% | 10.9% | 12.7% | 12.9% | 0.28 | 16.5% | -50.6% |
| 47 | Nippon India Focused Fund | 34 | 52 | -1.4% | 3.9% | -1.5% | 8.3% | 9.9% | 12.8% | 0.14 | 16.7% | -43.4% |
| 48 | Nippon India Consumption Fund | 41 | 48 | 2.6% | 7.5% | -8.1% | 9.1% | 12.0% | 13.2% | 0.18 | 16.8% | -31.0% |
| 49 | Nippon India Consumption Fund | 41 | 48 | 2.6% | 7.5% | -8.1% | 9.1% | 12.0% | 13.2% | 0.18 | 16.8% | -31.0% |
| 50 | Nippon India Active Momentum Fund | 69 | n/a | 2.3% | 10.6% | 8.8% | n/a | n/a | n/a | 0.64 | n/a | -11.8% |
| 51 | Nippon India MNC Fund | 27 | n/a | -2.4% | 4.4% | -1.3% | n/a | n/a | n/a | n/a | n/a | -13.1% |
Amber Singhania's full record
Amber Singhania currently runs 52 funds, across Aggressive Hybrid Fund, Arbitrage Fund, Conservative Hybrid Fund, Corporate Bond Fund and more, with about ₹697,294 Cr under management. The book's average King Score is 71.5/100. Their strongest fund by King Score is Nippon India Corporate Bond Fund (91/100); Nippon India Pharma Fund ranks #32 of 52 in their book.
Tap any column heading to sort.
| # | Fund | RS | King | 3M | 6M | 1Y | 3Y CAGR | 5Y CAGR | 10Y CAGR | Sharpe | Roll 3Y | Worst fall |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Nippon India Corporate Bond Fund | 88 | 91 | 1.3% | 3.0% | 5.5% | 7.5% | 6.8% | 7.3% | 0.86 | 8.0% | -1.7% |
| 2 | Nippon India Nivesh Lakshya Long Duration Fund | 87 | 90 | 1.1% | 1.8% | 2.2% | 6.1% | 5.6% | n/a | -0.11 | 6.9% | -5.8% |
| 3 | Nippon India Liquid Fund | 97 | 86 | 1.7% | 3.5% | 6.6% | 7.0% | 6.4% | 6.2% | 1.34 | 6.9% | -0.2% |
| 4 | Nippon India Low Duration Fund | 96 | 86 | 1.7% | 3.4% | 6.6% | 7.5% | 6.7% | 7.0% | 1.58 | 7.5% | -2.0% |
| 5 | Nippon India Money Market Fund | 91 | 86 | 1.9% | 3.5% | 6.6% | 7.4% | 6.8% | 6.8% | 1.59 | 7.4% | -0.9% |
| 6 | Nippon India Money Market Fund | 91 | 86 | 1.9% | 3.5% | 6.6% | 7.4% | 6.8% | 6.8% | 1.59 | 7.4% | -0.9% |
| 7 | Nippon India Short Duration Fund | 86 | 83 | 1.2% | 2.8% | 5.8% | 7.7% | 6.7% | 7.3% | 1.11 | 7.9% | -2.9% |
| 8 | Nippon India Conservative Hybrid Fund | 99 | 82 | 1.6% | 3.5% | 7.0% | 8.5% | 8.2% | 6.0% | 0.97 | 8.5% | -18.9% |
| 9 | Nippon India Multi Asset Allocation Fund | 87 | 81 | 0.9% | 4.8% | 11.7% | 18.3% | 15.2% | n/a | 1.16 | 18.4% | -9.5% |
| 10 | Nippon India Ultra Short Duration Fund | 97 | 80 | 1.9% | 3.7% | 7.1% | 7.6% | 7.0% | n/a | 2.0 | 7.0% | -5.2% |
| 11 | Nippon India Gilt Fund | 84 | 80 | 1.2% | 2.7% | 3.9% | 6.3% | 5.6% | 7.4% | -0.07 | 9.3% | -6.5% |
| 12 | Nippon India Balanced Advantage Fund | 81 | 80 | 1.0% | 4.0% | 2.4% | 10.2% | 9.5% | 11.0% | 0.43 | 12.9% | -22.8% |
| 13 | Nippon India Low Duration Fund | 96 | 78 | 1.7% | 3.4% | 6.6% | 7.5% | 6.7% | 7.0% | 1.58 | 7.2% | -10.5% |
| 14 | Nippon India Large Cap Fund | 34 | 78 | -1.7% | 0.1% | -5.2% | 9.9% | 12.6% | 13.9% | 0.24 | 16.8% | -40.0% |
| 15 | Nippon India Large Cap Fund | 34 | 78 | -1.7% | 0.1% | -5.2% | 9.9% | 12.6% | 13.9% | 0.24 | 16.8% | -40.0% |
| 16 | Nippon India Mid Cap Fund | 38 | 77 | -0.5% | 7.8% | 5.7% | 17.3% | 17.2% | 18.1% | 0.62 | 22.0% | -35.3% |
| 17 | Nippon India Mid Cap Fund | 38 | 77 | -0.5% | 7.8% | 5.7% | 17.3% | 17.2% | 18.1% | 0.62 | 22.0% | -35.3% |
| 18 | Nippon India Arbitrage Fund | 86 | 76 | 1.6% | 3.1% | 6.7% | 7.3% | 6.8% | 6.5% | 0.83 | 6.9% | -0.6% |
| 19 | Nippon India Dynamic Bond Fund | 69 | 76 | 0.8% | 1.8% | 5.2% | 7.2% | 6.2% | 6.7% | 0.36 | 7.6% | -8.5% |
| 20 | Nippon India Vision Large & Mid Cap Fund | 20 | 76 | -0.9% | 3.8% | -1.5% | 13.4% | 12.3% | 12.7% | 0.44 | 16.9% | -45.0% |
| 21 | Nippon India Vision Large & Mid Cap Fund | 20 | 76 | -0.9% | 3.8% | -1.5% | 13.4% | 12.3% | 12.7% | 0.44 | 16.9% | -45.0% |
| 22 | Nippon India Credit Risk Fund | 75 | 75 | 1.8% | 3.9% | 8.0% | 8.9% | 7.9% | 6.6% | 2.65 | 8.7% | -13.8% |
| 23 | Nippon India Taiwan Equity Fund | 99 | 74 | -6.9% | 38.3% | 112.8% | 58.2% | n/a | n/a | 1.33 | 36.4% | -44.8% |
| 24 | Nippon India Medium Duration Fund | 98 | 74 | 2.9% | 3.3% | 6.6% | 8.6% | 6.9% | 3.8% | 1.09 | 7.0% | -29.8% |
| 25 | Nippon India Gilt Fund | 84 | 74 | 1.2% | 2.7% | 3.9% | 6.3% | 5.6% | 7.4% | -0.07 | 9.2% | -11.8% |
| 26 | Nippon India Value Fund | 28 | 72 | -2.4% | 1.4% | -3.6% | 12.9% | 13.0% | 14.8% | 0.4 | 19.1% | -38.6% |
| 27 | Nippon India US Equity Opportunities Fund | 87 | 71 | 6.8% | 17.5% | 16.5% | 19.5% | 12.2% | 16.3% | 0.76 | 16.7% | -30.8% |
| 28 | Nippon India Medium Duration Fund | 72 | 71 | 1.4% | 2.9% | 6.2% | 8.3% | 6.8% | 3.7% | 0.97 | 7.0% | -29.8% |
| 29 | Nippon India Innovation Fund | 68 | 71 | 4.6% | 12.8% | 0.8% | 13.9% | n/a | n/a | 0.49 | n/a | -21.5% |
| 30 | Nippon India Japan Equity Fund | 89 | 70 | 4.1% | 15.1% | 28.8% | 20.8% | 10.1% | 11.9% | 0.75 | 8.1% | -29.9% |
| 31 | Nippon India Japan Equity Fund | 89 | 70 | 4.1% | 15.1% | 28.8% | 20.8% | 10.1% | 11.9% | 0.75 | 8.1% | -29.9% |
| 32 | Nippon India Pharma Fund (this page) | 75 | 69 | 4.7% | 11.9% | 8.9% | 17.5% | 13.1% | 15.4% | 0.82 | 19.9% | -24.0% |
| 33 | Nippon India Pharma Fund | 75 | 69 | 4.7% | 11.9% | 8.9% | 17.5% | 13.1% | 15.4% | 0.82 | 19.9% | -24.0% |
| 34 | Nippon India ELSS Tax Saver Fund | 31 | 68 | -1.6% | 2.2% | -0.8% | 11.1% | 11.2% | 10.5% | 0.3 | 15.5% | -51.9% |
| 35 | Nippon India Power & Infra Fund | 45 | 67 | -3.3% | 7.6% | 6.0% | 17.2% | 19.8% | 17.4% | 0.57 | 17.9% | -53.2% |
| 36 | Nippon India Power & Infra Fund | 45 | 67 | -3.3% | 7.6% | 6.0% | 17.2% | 19.8% | 17.4% | 0.57 | 17.9% | -53.2% |
| 37 | Nippon India Aggressive Hybrid Fund | 57 | 66 | -0.1% | 2.8% | -0.2% | 9.8% | 10.6% | 9.8% | 0.3 | 13.9% | -42.4% |
| 38 | Nippon India Gilt Fund | 84 | 64 | 1.2% | 2.7% | 3.9% | 6.3% | 5.6% | 7.4% | -0.07 | 6.9% | -36.5% |
| 39 | Nippon India Quant Fund | 23 | 64 | -1.0% | 0.4% | -1.3% | 12.7% | 12.5% | 13.7% | 0.38 | 13.5% | -32.8% |
| 40 | Nippon India Quant Fund | 23 | 64 | -1.0% | 0.4% | -1.3% | 12.7% | 12.5% | 13.7% | 0.38 | 13.6% | -32.8% |
| 41 | Nippon India Small Cap Fund | 40 | 62 | 3.3% | 17.1% | 7.2% | 14.3% | 18.2% | 20.9% | 0.46 | 25.8% | -48.6% |
| 42 | Nippon India Small Cap Fund | 40 | 62 | 3.3% | 17.1% | 7.2% | 14.3% | 18.2% | 20.9% | 0.46 | 25.8% | -48.6% |
| 43 | Nippon India Flexi Cap Fund | 40 | 56 | -0.1% | 5.6% | -2.1% | 9.4% | 10.4% | n/a | 0.19 | 17.2% | -19.8% |
| 44 | Nippon India Multi Cap Fund | 15 | 56 | -1.2% | 3.9% | -2.8% | 12.1% | 16.1% | 15.3% | 0.37 | 17.3% | -42.8% |
| 45 | Nippon India Multi Cap Fund | 15 | 56 | -1.2% | 3.9% | -2.8% | 12.1% | 16.1% | 15.3% | 0.37 | 17.3% | -42.8% |
| 46 | Nippon India Banking & Financial Services Fund | 40 | 55 | -0.5% | 2.5% | 2.7% | 10.9% | 12.7% | 12.9% | 0.28 | 16.5% | -50.6% |
| 47 | Nippon India Banking & Financial Services Fund | 40 | 55 | -0.5% | 2.5% | 2.7% | 10.9% | 12.7% | 12.9% | 0.28 | 16.5% | -50.6% |
| 48 | Nippon India Focused Fund | 34 | 52 | -1.4% | 3.9% | -1.5% | 8.3% | 9.9% | 12.8% | 0.14 | 16.7% | -43.4% |
| 49 | Nippon India Consumption Fund | 41 | 48 | 2.6% | 7.5% | -8.1% | 9.1% | 12.0% | 13.2% | 0.18 | 16.8% | -31.0% |
| 50 | Nippon India Consumption Fund | 41 | 48 | 2.6% | 7.5% | -8.1% | 9.1% | 12.0% | 13.2% | 0.18 | 16.8% | -31.0% |
| 51 | Nippon India Active Momentum Fund | 69 | n/a | 2.3% | 10.6% | 8.8% | n/a | n/a | n/a | 0.64 | n/a | -11.8% |
| 52 | Nippon India MNC Fund | 27 | n/a | -2.4% | 4.4% | -1.3% | n/a | n/a | n/a | n/a | n/a | -13.1% |
A caveat worth keeping: funds often have co-managers, and results belong to the whole team and process rather than one person. A manager's book tells you about their range and consistency, not a guarantee of skill.
Cost & fund basics
| Detail | Value |
|---|---|
| Expense ratio (Direct) | 0.79% |
| Exit load | ≈1% if redeemed within 1 year (typical) |
| Minimum investment | ₹5000 |
| Fund size (AUM) | ₹8,635 Cr |
| Age | 13.7 years |
| Plan / Option | Direct · Growth |
| Benchmark | NIFTY_PHARMA |
How Nippon India Pharma Fund compares to peers
| Fund | RS | King | 3Y CAGR |
|---|---|---|---|
| HDFC Transportation and Logistics Fund | 82 | 89 | 24.1% |
| ICICI Prudential Transportation And Logistics Fund | 78 | 87 | 21.1% |
| ICICI Prudential Innovation Fund | 56 | 87 | 17.8% |
| LIC MF Healthcare Fund | 91 | 87 | 21.4% |
| Kotak Manufacture in India Fund | 81 | 83 | 19.1% |
| HDFC Defence Fund | 87 | 83 | 36.0% |
Overlap warning: funds in the same category often own many of the same stocks - holding several rarely adds the diversification people expect.
What these numbers mean
RS rating (1-99) ranks a fund's recent momentum against its category - higher is stronger right now. King Score (0-100) is a long-term quality composite (returns, consistency, drawdown, risk-adjusted return) versus peers. Max drawdown is the worst peak-to-bottom fall the fund has ever experienced. Rolling returns test every possible start date, so one lucky (or unlucky) entry point can't distort the picture. Every formula behind this page is public - see how we calculate every number.
Nippon India Pharma Fund review: the bottom line
Related
Frequently asked questions
Is Nippon India Pharma Fund a good mutual fund?
That depends on your goals and risk tolerance - this is descriptive research, not advice. On the numbers, Nippon India Pharma Fund scores 69/100 on our King Score and RS 75/99 within its category, has compounded 17.54% a year over three years, and its worst drawdown was -24.02%. Compare those against your needs and the peer table above.
What is the NAV of Nippon India Pharma Fund today?
The latest NAV is ₹630.52 (as of 2026-09-16). NAV (net asset value) is the per-unit price of the fund, published every business day by the AMC.
What is the last 10 years return of Nippon India Pharma Fund?
Over the last 10 years Nippon India Pharma Fund has returned about 15.45% a year (CAGR). In rupees: ₹1 lakh invested 10 years ago would be roughly ₹4.2 lakh today, before tax. See the year-by-year table above for how uneven the ride was.
What is the expense ratio of Nippon India Pharma Fund?
The Direct-plan expense ratio is 0.79% a year. The Direct plan is cheaper than the Regular plan because it carries no distributor commission - over decades that gap compounds meaningfully.
Who is the fund manager of Nippon India Pharma Fund?
Nippon India Pharma Fund is managed by Sailesh Raj Bhan; Kinjal Desai; Amber Singhania.
Is Nippon India Pharma Fund safe? How risky is it?
No market-linked fund is 'safe' in the fixed-deposit sense - the honest question is how deep its falls get. Its worst historical drawdown was -24.02% - ₹1 lakh briefly becoming about ₹75,980. As a sectoral & thematic fund, its risk profile is typical of that category. Look at the drawdown, volatility and bear-market figures above and ask whether you could stay invested through the bad stretches.
Is Nippon India Pharma Fund good for SIP?
We can't tell you what to do, but here is what actually happened: a ₹10,000 monthly SIP over the last 10 years grew ₹12.1 lakh into about ₹32 lakh (XIRR 18.47%). SIPs average your entry price, which helps most in funds that swing hard - check the crash-behaviour section above to see how it treats investors in bad markets.
What are the SIP returns of Nippon India Pharma Fund?
A ₹10,000/month SIP over 10 years would have grown to about ₹3,201,063 (an XIRR of 18.47%) on ₹1,210,000 invested, using the fund's actual NAV history. See the SIP table above for other durations.
How does Nippon India Pharma Fund rank among similar funds?
On 3-year returns it sits around the 83th percentile of its category, and its consistency ranks 44th percentile. 100th is best-in-class, 50th is average. See the category-ranking section above.
Is Nippon India Pharma Fund tax-efficient / what about capital gains?
As a sectoral & thematic fund, gains follow the rules for its asset class - equity-oriented funds are taxed differently from debt. All returns on this page are pre-tax; your actual post-tax return depends on your holding period and slab. This is descriptive information, not tax advice.
Direct or Regular plan - which is shown here?
All figures on this page are for the Direct-Growth plan (no distributor commission, lower cost). Returns are pre-tax; capital-gains tax depends on your own holding period and slab.
See Nippon India Pharma Fund live in the MF Terminal
Everything above is a static snapshot. The terminal is where you actually research it:
- Interactive price chart with EMAs & RSI
- The RS line plotted against its benchmark
- Full holdings, sector mix & portfolio overlap
- Point-in-time backtester & portfolio doctor
- Compare it side-by-side with any peer
- Screen 1,600+ funds on the same metrics
Data: AMFI NAV history, NSE indices, BSE StAR and monthly disclosures. All figures are pre-tax. Descriptive research and education only - nothing here is investment advice or a recommendation to buy, sell or hold any fund. Past performance does not guarantee future returns.